0591-2466 : Flutamide 125 mg Oral Capsule
NDC: | 0591-2466 |
Labeler: | Watson Laboratories, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Oral Capsule |
Application #: | ANDA075820 |
Rev. Date: |
Appearance:
Markings: | WPI;2227 |
Shapes: |
Capsule |
Colors: |
![]() ![]() |
Size (mm): | 22 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |

The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 0591-2466-18: 180 CAPSULE IN 1 BOTTLE, PLASTIC (0591‑2466‑18)
Active Ingredients:
- Flutamide
Dosage Strength:
- 125 mg
Inactive Ingredients:
- Lactose Monohydrate
- Magnesium Stearate
- Povidone
- Starch, Pregelatinized Corn
- Sodium Lauryl Sulfate
- Ferric Oxide Black
- Gelatin
- Ferric Oxide Red
- Ferric Oxide Yellow
- Titanium Dioxide
- D&c Yellow No. 10
- Fd&c Blue No. 1
- Fd&c Blue No. 2
- Fd&c Red No. 40
- Butyl Alcohol
- Propylene Glycol
Pharmaceutical Classes:
- Androgen Receptor Antagonists [MoA]
- Androgen Receptor Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 0172-4960 Flutamide 125 mg Oral Capsule by Ivax Pharmaceuticals, Inc.
- 49884-753 Flutamide 125 mg Oral Capsule by Par Pharmaceutical Inc.
- 55567-150 Flutamide 125 mg Oral Capsule by Genpharm
- 60429-272 Flutamide 125 mg Oral Capsule by Golden State Medical Supply, Inc.
- 69097-915 Flutamide 125 mg Oral Capsule by Cipla USA Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0591-2465Next: 0591-2467 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.